Searching for sharp drops in the incidence of pandemic a/H1N1 influenza by single year of age

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Jacobs, Jessica Hartman ^a   Archer, Brett Nicholas ^b   Baker, Michael G ^c   Cowling, Benjamin J ^d   Heffernan, Richard T ^e   Mercer, Geoff ^f   Uez, Osvaldo ^g   Hanshaoworakul, Wanna ^h   Viboud, Cécile ⁱ   Schwartz, Joel ^a   Tchetgen Tchetgen, Eric ^a   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

^f The Australian National University   (Australia)

^g Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^h MINISTRY OF PUBLIC HEALTH   (Thailand)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CURVE FITTING; FEMALE; GENDER; HOSPITALIZATION; HUMAN; INCIDENCE; INCIDENCE DISCONTINUITY; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; STRATIFIED SAMPLE; VIRUS IMMUNITY;

ORTHOMYXOVIRIDAE;

EID: 84864453832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042328     Document Type: Article

References (40)

1. Miller MA, Viboud C, Balinska M, Simonsen L, ((2009)) The signature features of influenza pandemics-implications for policy. N Engl J Med 360:: 2595--2598.
2. Simonsen L, Olson D, Viboud C, Heiman E, Taylor R,et al. (2005) Pandemic influenza and mortality: past evidence and projections for the future. In: Knobler SL, Mack A, Mahmoud A, Lemon SM, editors. The threat of pandemic influenza: are we ready? Workshop summary. Washington, DC: National Academies Press. 89-114.
3. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. ((2009)) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:: 2605--2615.
4. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. ((2009)) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361:: 1935--1944.
5. Reichert T, Chowell G, Nishiura H, Christensen RA, McCullers JA, ((2010)) Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis 10:: 5.
6. Vaillant L, La Ruche G, Tarantola A, Barboza P, ((2009)) Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 14.
7. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L, ((2010)) Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons. PLoS Curr. pp. RRN1153.
8. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, et al. ((2011)) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8:: e1001053.
9. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. ((2009)) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361:: 1945--1952.
10. Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, et al. ((2009)) Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361:: 2000--2001.
11. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. ((2009)) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106:: 20365--20370.
12. Balter S, Gupta LS, Lim S, Fu J, Perlman SE, ((2010)) Pandemic (H1N1) 2009 surveillance for severe illness and response, New York, New York, USA, April-July 2009. Emerg Infect Dis 16:: 1259--1264.
13. Statistics South Africa (2009) Mid-year population estimates, 2009. Available: http://www.statssa.gov.za. Accessed 2012 Mar 1.
14. Siegel JS, Swanson DA, Shryock HS (2004) The methods and materials of demography. Boston: Elsevier/Academic Press. 819 p.
15. Instituto Nacional de Estadística y Censos (2010) Cuadro P2. Total del país. Población total por sexo e índice de masculinidad, según edad en años simples y grupos quinquenales de edad. Año 2010 [Table P2. Total in the country. Total population by sex and sex ratio by age in single years and five year age groups. Year 2010.]. Available: http://www.indec.gov.ar/. Accessed 2012 Jan 12.
16. Sonderegger D (2008) SiZer: Significant Zero Crossings. 0.1-4.0 ed. Available: http://cran.r-project.org/web/packages/SiZer/SiZer.pdf. Accessed 2011 Jul 7.
17. R Development Core Team (2009) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available: http://cran.r-project.org/. Accessed 2012 Jul 13.
18. Chaudhuri P, Marron JS, ((1999)) SiZer for exporation of structures in curves. J Am Stat Assoc 94(447):: 807--823.
19. Lemaitre M, Leruez-Ville M, De Lamballerie XN, Salez N, Garrone P, et al. ((2011)) Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus. Clin Microbiol Infect 17:: 732--737.
20. Adalja AA, Henderson DA, ((2010)) Original antigenic sin and pandemic (H1N1) 2009. Emerg Infect Dis 16:: 1028--1029.
21. Kim JH, Skountzou I, Compans R, Jacob J, ((2009)) Original antigenic sin responses to influenza viruses. J Immunol 183:: 3294--3301.
22. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. ((2009)) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:: 197--201.
23. Smith GJD, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. ((2009)) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:: 1122--1125.
24. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, et al. ((2010)) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:: 357--360.
25. Wei CJ, Boyington JC, Dai K, Houser KV, Pearce MB, et al. ((2010)) Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med 2:: 24ra21.
26. Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, et al. ((2010)) Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 6:: e1000745.
27. World Health Organization ((2010)) Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 85:: 229--235.
28. Broberg E, Nicoll A, Amato-Gauci A, ((2011)) Seroprevalence to influenza A(H1N1) 2009 virus-where are we? Clin Vaccine Immunol 18:: 1205--1212.
29. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. ((2010)) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 5:: e13211.
30. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, et al. ((2010)) High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 15.
31. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, et al. ((2010)) Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28:: 3558--3562.
32. Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, et al. ((2011)) Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 203:: 158--167.
33. Booy R, Khandaker G, Heron LG, Yin J, Doyle B, et al. ((2011)) Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians. Med J Aust 194:: 19--23.
34. McVernon J, Laurie K, Nolan T, Owen R, Irving D, et al. ((2010)) Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October- December 2009. Euro Surveill 15.
35. Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, et al. ((2010)) Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. J Med Virol 82:: 1809--1815.
36. Prachayangprecha S, Makkoch J, Payungporn S, Chieochansin T, Vuthitanachot C, et al. ((2010)) Serological analysis of human pandemic influenza (H1N1) in Thailand. J Health Popul Nutr 28:: 537--544.
37. Khurana S, Verma N, Talaat KR, Karron RA, Golding H, ((2012)) Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender. J Infect Dis 205:: 610--620.
38. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, et al. ((2008)) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455:: 532--536.
39. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. ((2010)) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375:: 1100--1108.
40. Klein SL, Passaretti C, Anker M, Olukoya P, Pekosz A, ((2010)) The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ 1:: 5.